Carin Canale-Theakston's Net Worth

$0

Estimate Recalculated Jul 22, 2024 04:13PM EST

Who is Carin Canale-Theakston?

Carin Canale-Theakston does not have any significant net worth to report based on the numbers we have. This is based on reported shares in Cidara Therapeutics, Inc..

SEC CIK

Carin Canale-Theakston's CIK is 0001841613

Past Insider Trading and Trends

2021 was Carin Canale-Theakston's most active year for acquiring shares with 2 total transactions. Carin Canale-Theakston's most active month to acquire stocks was the month of May. 2023 saw Carin Canale-Theakston paying a total of $0.00 for 42,500 shares, this is the most they've acquired in one year.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Cidara Therapeutics, Inc. (CDTX) Snapshot price: $0.6601

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jul 18
Form 4
—
0
—
—
0
Jun 22
Form 4
—
0
—
—
0
Jun 22
Form 4
—
0
—
—
0
Jun 23
Form 4
—
0
—
—
0
Jan 22
Form 3
—
0
—
—
0
No matching records found